JP2021527700A5 - - Google Patents
Info
- Publication number
- JP2021527700A5 JP2021527700A5 JP2020571400A JP2020571400A JP2021527700A5 JP 2021527700 A5 JP2021527700 A5 JP 2021527700A5 JP 2020571400 A JP2020571400 A JP 2020571400A JP 2020571400 A JP2020571400 A JP 2020571400A JP 2021527700 A5 JP2021527700 A5 JP 2021527700A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- subunit
- amino acid
- charge
- heterodimer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023098823A JP7452932B2 (ja) | 2018-06-21 | 2023-06-15 | ヘテロ二量体タンパク質及びその使用 |
| JP2024032407A JP2024057087A (ja) | 2018-06-21 | 2024-03-04 | ヘテロ二量体タンパク質及びその使用 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862688167P | 2018-06-21 | 2018-06-21 | |
| US62/688,167 | 2018-06-21 | ||
| US201862703248P | 2018-07-25 | 2018-07-25 | |
| US62/703,248 | 2018-07-25 | ||
| PCT/US2019/038451 WO2019246508A1 (en) | 2018-06-21 | 2019-06-21 | Heterodimeric proteins and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023098823A Division JP7452932B2 (ja) | 2018-06-21 | 2023-06-15 | ヘテロ二量体タンパク質及びその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021527700A JP2021527700A (ja) | 2021-10-14 |
| JP2021527700A5 true JP2021527700A5 (cg-RX-API-DMAC7.html) | 2022-06-28 |
| JP7439372B2 JP7439372B2 (ja) | 2024-02-28 |
Family
ID=68983045
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020571400A Active JP7439372B2 (ja) | 2018-06-21 | 2019-06-21 | ヘテロ二量体タンパク質及びその使用 |
| JP2023098823A Active JP7452932B2 (ja) | 2018-06-21 | 2023-06-15 | ヘテロ二量体タンパク質及びその使用 |
| JP2024032407A Pending JP2024057087A (ja) | 2018-06-21 | 2024-03-04 | ヘテロ二量体タンパク質及びその使用 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023098823A Active JP7452932B2 (ja) | 2018-06-21 | 2023-06-15 | ヘテロ二量体タンパク質及びその使用 |
| JP2024032407A Pending JP2024057087A (ja) | 2018-06-21 | 2024-03-04 | ヘテロ二量体タンパク質及びその使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US10995127B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3810172A4 (cg-RX-API-DMAC7.html) |
| JP (3) | JP7439372B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20210025054A (cg-RX-API-DMAC7.html) |
| CN (1) | CN112566650A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2019290192A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112020026112A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3103975A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2020014031A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2019246508A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112566650A (zh) * | 2018-06-21 | 2021-03-26 | 沙塔克实验室有限公司 | 异二聚体蛋白及其用途 |
| WO2021041958A1 (en) * | 2019-08-30 | 2021-03-04 | Shattuck Labs. Inc. | Chimeric proteins in autoimmunity |
| US20230226202A1 (en) * | 2020-03-30 | 2023-07-20 | Proviva Therapeutics (Hong Kong) Limited | Il-2/il15 compositions and methods of use thereof |
| US12012441B2 (en) | 2020-10-26 | 2024-06-18 | Neptune Biosciences Llc | Engineered human IL-21 cytokines and methods for using the same |
| KR20240007256A (ko) | 2021-05-12 | 2024-01-16 | 어플라이드 바이오메디컬 사이언스 인스티튜트 | 이황화 결합된 결합 폴리펩타이드의 스크리닝 및 발현 방법 |
| US20240262893A1 (en) | 2021-05-12 | 2024-08-08 | Applied Biomedical Science Institute | Binding polypeptides against sars cov-2 and uses thereof |
| EP4511054A4 (en) * | 2022-04-20 | 2026-07-22 | Neptune Biosciences Llc | ORTHOGONAL CYTOKINE/IL-21 RECEPTOR SYSTEMS |
| CN119546322A (zh) | 2022-05-16 | 2025-02-28 | 恩科弗洛斯生物科学股份有限公司 | 血脑屏障易位肽和相关分子及其使用方法 |
| WO2024019984A1 (en) * | 2022-07-18 | 2024-01-25 | Cargo Therapeutics, Inc. | Cytokine receptor switch polypeptides and uses thereof |
| AU2023379740A1 (en) | 2022-11-16 | 2025-05-29 | Applied Biomedical Science Institute | Fusion polypeptides and binding peptides and methods for producing and using same |
| WO2024123812A1 (en) | 2022-12-05 | 2024-06-13 | Shattuck Labs, Inc. | Fusion proteins for the treatment of cardiometabolic diseases |
| WO2025133115A1 (en) * | 2023-12-21 | 2025-06-26 | Ose Immunotherapeutics | Lipid-based nanoparticles comprising il-35 |
| CN122555718A (zh) * | 2023-12-27 | 2026-08-11 | 上海药明生物技术有限公司 | 重组il-27蛋白及其制备方法 |
| CN117986386B (zh) * | 2024-02-06 | 2024-11-29 | 康立泰生物医药(青岛)有限公司 | 重组人白细胞介素-35及其制备方法和应用 |
| US12698309B2 (en) * | 2024-08-01 | 2026-08-04 | Twilight Bioscience, Inc. | HERV-K (HML-2) Env analog fusion proteins for antigen specific immunotherapy and methods of use |
| WO2026093414A1 (en) * | 2024-10-30 | 2026-05-07 | Ose Immunotherapeutics | Lipid-based nanoparticles comprising membrane il-35 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995031480A1 (en) * | 1994-05-18 | 1995-11-23 | S.P.I. Synthetic Peptides Incorporated | Heterodimer polypeptide immunogen carrier composition and method |
| IT1274350B (it) * | 1994-12-06 | 1997-07-17 | Angeletti P Ist Richerche Bio | Antagonisti di interleuchina-6(il-6) che consistono di forme solubili del ricettore alfa di il-6, mutate nell'interfaccia che si lega a gp 130 |
| AU706504B2 (en) | 1996-02-20 | 1999-06-17 | Merck Serono Sa | Hybrid proteins which form heterodimers |
| ES2221717T3 (es) * | 1997-12-08 | 2005-01-01 | Emd Lexigen Research Center Corp. | Proteinas de fusion heterodimeras utiles para inmunoterapia dirigida e inmunoestimulacion general. |
| SK782002A3 (en) | 1999-07-21 | 2003-08-05 | Lexigen Pharm Corp | FC fusion proteins for enhancing the immunogenicity of protein and peptide antigens |
| WO2001010912A1 (en) * | 1999-08-09 | 2001-02-15 | Lexigen Pharmaceuticals Corp. | Multiple cytokine-antibody complexes |
| AU2001290524A1 (en) * | 2000-08-08 | 2002-02-18 | Zymogenetics Inc. | Soluble zcytor 11 cytokine receptors |
| EP1781708B1 (en) * | 2004-07-09 | 2011-02-16 | Variety Children's Hospital d/b/a/ Miami Children's Hospital | Materials and methods for immune system stimulation |
| EP2072527A1 (en) * | 2007-12-21 | 2009-06-24 | Altonabiotec AG | Fusion polypeptides comprising a SHBG dimerization component and uses thereof |
| CN102712696A (zh) * | 2009-09-16 | 2012-10-03 | 弗·哈夫曼-拉罗切有限公司 | 包含卷曲螺旋和/或系链的蛋白质复合体及其用途 |
| US20130089554A1 (en) | 2009-12-29 | 2013-04-11 | Emergent Product Development Seattle, Llc | RON Binding Constructs and Methods of Use Thereof |
| WO2011119484A1 (en) * | 2010-03-23 | 2011-09-29 | Iogenetics, Llc | Bioinformatic processes for determination of peptide binding |
| UY35148A (es) * | 2012-11-21 | 2014-05-30 | Amgen Inc | Immunoglobulinas heterodiméricas |
| EP3587448B1 (en) * | 2013-03-15 | 2021-05-19 | Xencor, Inc. | Heterodimeric proteins |
| US10017545B2 (en) * | 2013-06-03 | 2018-07-10 | University Of Maryland, College Park | Compositions and vaccines comprising vesicles and methods of using the same |
| CA2957148A1 (en) | 2014-09-17 | 2016-03-24 | Genentech, Inc. | Immunoconjugates comprising anti-her2 antibodies and pyrrolobenzodiazepines |
| CN104403004B (zh) * | 2014-11-24 | 2017-10-13 | 苏州丁孚靶点生物技术有限公司 | 抗体‑干扰素异二聚体的制备和用途 |
| SG11201707182WA (en) * | 2015-03-05 | 2017-10-30 | Hutchinson Fred Cancer Res | Immunomodulatory fusion proteins and uses thereof |
| MX2018001208A (es) * | 2015-07-26 | 2018-03-26 | Molecular Templates Inc | Moleculas con direccion a las celulas que comprenden efectores de la subunidad a de la toxina shiga y epitopos de celulas-t cd8+. |
| SG10201913573UA (en) * | 2015-10-01 | 2020-03-30 | Heat Biologics Inc | Compositions and methods for adjoining type i and type ii extracellular domains as heterologous chimeric proteins |
| CN108367069B (zh) | 2015-12-14 | 2022-08-23 | 宏观基因有限公司 | 对于pd-1和ctla-4具有免疫反应性的双特异性分子及其使用方法 |
| US10906957B2 (en) * | 2016-09-27 | 2021-02-02 | Epicentrx, Inc. | Immunomodulatory fusion proteins |
| US12447213B2 (en) * | 2016-10-07 | 2025-10-21 | The Broad Institute, Inc. | Modulation of novel immune checkpoint targets |
| IL268198B2 (en) * | 2017-02-27 | 2024-10-01 | Shattuck Labs Inc | Tigit- and light-based chimeric proteins |
| CN112566650A (zh) * | 2018-06-21 | 2021-03-26 | 沙塔克实验室有限公司 | 异二聚体蛋白及其用途 |
| BR112021013193A2 (pt) * | 2019-01-07 | 2021-09-28 | Shattuck Labs, Inc. | Proteínas heterodiméricas para modulação de células t gama delta |
| WO2021041958A1 (en) * | 2019-08-30 | 2021-03-04 | Shattuck Labs. Inc. | Chimeric proteins in autoimmunity |
-
2019
- 2019-06-21 CN CN201980053803.4A patent/CN112566650A/zh active Pending
- 2019-06-21 WO PCT/US2019/038451 patent/WO2019246508A1/en not_active Ceased
- 2019-06-21 EP EP19823119.3A patent/EP3810172A4/en not_active Withdrawn
- 2019-06-21 KR KR1020217001659A patent/KR20210025054A/ko not_active Ceased
- 2019-06-21 MX MX2020014031A patent/MX2020014031A/es unknown
- 2019-06-21 JP JP2020571400A patent/JP7439372B2/ja active Active
- 2019-06-21 AU AU2019290192A patent/AU2019290192A1/en not_active Abandoned
- 2019-06-21 BR BR112020026112-2A patent/BR112020026112A2/pt not_active Application Discontinuation
- 2019-06-21 CA CA3103975A patent/CA3103975A1/en active Pending
- 2019-09-16 US US16/571,853 patent/US10995127B2/en active Active
-
2021
- 2021-03-24 US US17/211,180 patent/US11780897B2/en active Active
-
2023
- 2023-01-17 US US18/155,218 patent/US20230220030A1/en not_active Abandoned
- 2023-06-15 JP JP2023098823A patent/JP7452932B2/ja active Active
-
2024
- 2024-03-04 JP JP2024032407A patent/JP2024057087A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6853317B2 (ja) | 高度に低下された受容体結合親和性を有するサイトカインを含むフソカイン | |
| US20220112260A1 (en) | Molecules that selectively activate regulatory t cells for the treatment of autoimmune diseases | |
| US7666622B2 (en) | Monomeric self-associating fusion polypeptides and therapeutic uses thereof | |
| JP2022058337A (ja) | 自己免疫疾患の治療のために制御性t細胞を選択的に活性化する分子 | |
| US20220275048A1 (en) | Dimer immunoadhesin, pharmaceutical compostion and use thereof | |
| JP7814759B2 (ja) | 二重特異性組換えタンパク質及びその使用 | |
| CN110437339A (zh) | 一种以白介素15为活性成分的融合蛋白型药物前体 | |
| JP2024521405A5 (cg-RX-API-DMAC7.html) | ||
| JPH08507676A (ja) | 可溶性オリゴマー蛋白質の調製法 | |
| RS55609B1 (sr) | Fc fuzioni proteini koji sadrže nove linkere ili aranžmane | |
| EP4019536A1 (en) | Immunocytokine, preparation for same, and uses thereof | |
| CN117500824A (zh) | 包含IL-10或TGF-β激动剂多肽的嵌合分子 | |
| CN113518823A (zh) | 多功能的融合蛋白及其用途 | |
| CA3149583A1 (en) | Chimeric proteins in autoimmunity | |
| CN112996819B (zh) | 细胞分选系统及使用方法 | |
| JP7796754B2 (ja) | インターロイキン-2ムテイン及びその使用 | |
| CN117561280A (zh) | 携带TGF-β的抗原呈递多肽复合物及其使用方法 | |
| CA3180251A1 (en) | Cytokine conjugates | |
| Zhan et al. | Fusion of HSA influences TNF-α neutralizing activity of shTNFRs | |
| US20250115657A1 (en) | Bispecific FC Fusion Proteins with sPD-1 and IL-15 | |
| CN116375880A (zh) | 融合蛋白及其制备方法和应用 | |
| US11555060B2 (en) | QTY FC fusion water soluble receptor proteins | |
| WO2026036390A1 (zh) | 白介素12突变体及其用途 | |
| HK40060282A (en) | Multi-functional fusion proteins and uses thereof |